Aldeyra Therapeutics Files 8-K
Ticker: ALDX · Form: 8-K · Filed: May 6, 2025 · CIK: 1341235
| Field | Detail |
|---|---|
| Company | Aldeyra Therapeutics, INC. (ALDX) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, 8-K, regulatory
Related Tickers: ALDX
TL;DR
ALDX filed an 8-K on May 6th for events on May 5th - details pending.
AI Summary
Aldeyra Therapeutics, Inc. filed an 8-K on May 6, 2025, reporting on events that occurred on May 5, 2025. The filing indicates it is a Regulation FD Disclosure, Other Events, and includes Financial Statements and Exhibits. Specific details regarding the nature of these events or any financial figures were not provided in the excerpt.
Why It Matters
This filing signals that Aldeyra Therapeutics has made a significant disclosure to the SEC, potentially impacting investors' understanding of the company's current status or future plans.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosure and does not inherently present new risks, but the content of the disclosure itself could be material.
Key Players & Entities
- Aldeyra Therapeutics, Inc. (company) — Registrant
- May 6, 2025 (date) — Filing Date
- May 5, 2025 (date) — Earliest Event Reported Date
- Lexington, MA (location) — Principal Executive Offices
FAQ
What specific events are being disclosed in this 8-K filing?
The provided excerpt does not specify the exact events; it only categorizes the filing as a Regulation FD Disclosure, Other Events, and includes Financial Statements and Exhibits.
What is the significance of the filing date and the date of the earliest event reported?
The filing date is May 6, 2025, and the earliest event reported is May 5, 2025, indicating the company is reporting on recent developments.
What is Aldeyra Therapeutics, Inc.'s principal executive office address?
The principal executive offices are located at 131 Hartwell Avenue, Suite 320, Lexington, MA 02421.
What is Aldeyra Therapeutics, Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number is 20-1968197.
What is the SIC code for Aldeyra Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Aldeyra Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Aldeyra Therapeutics, Inc. (ALDX).